Pfizer-BioNTech

WASHINGTON (AP) — U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old while awaiting data on a three-dose course, aiming to clear the way... Read More

WASHINGTON -- The Food and Drug Administration on Monday granted full approval to Pfizer-BioNTech’s coronavirus vaccine for people 16 and over, making it the first to move beyond emergency use status in the United States. The approval comes as parts... Read More

WASHINGTON -- Americans who got the Moderna or Pfizer-BioNTech coronavirus vaccines will be able to obtain booster shots eight months after the date of their second doses, the Biden administration announced Wednesday. Because of the timing element, those who were... Read More

WASHINGTON — Recent studies conducted by Pfizer-BioNTech and results of a follow-up to Phase III trials confirmed that protection against COVID-19 stays high — over 91% — for at least six months after receiving two doses of the Pfizer vaccine.... Read More

WASHINGTON - The U.S. Food and Drug Administration announced Monday the Pfizer-BioNTech vaccine has been approved for emergency use for adolescents ages 12 to 15 years of age.  “Parents and guardians can rest assured that the agency undertook a rigorous... Read More

WASHINGTON - The Smithsonian’s National Museum of American History has aquired the vial that contained the first dose of COVID-19 vaccine administered in the United States as part of its plans to document the global pandemic and “this extraordinary period... Read More

WASHINGTON - The Food and Drug Administration has relaxed the rules around storage and transportation for some coronavirus vaccines in order to speed up the vaccine rollout. Frozen vials of Pfizer-BioNTech's coronavirus vaccine will be allowed to be kept at... Read More